Emerging data suggests we may have been overzealous with systemic corticosteroid prescribing and that allowing patients to self-manage their exacerbations with steroid rescue therapy may be harmful. However, we can now identify a subgroup of COPD patients who might benefit from systemic corticosteroids to treat their exacerbation.
Guest Authors: Hope Shrader Sherman, PharmD and Maricar Conson, PharmD, BCACP
Music by Good Talk
Create your
podcast in
minutes
It is Free